05:34 PM EST, 03/08/2024 (MT Newswires) -- Steven Gannon, Director, on March 07, 2024, sold 13,000 shares in Xenon Pharmaceuticals ( XENE ) for $601,615. Following the Form 4 filing with the SEC, Gannon has control over a total of 2,000 shares of the company, with 2,000 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1582313/000095017024028788/xslF345X03/ownership.xml